Equity Overview
Price & Market Data
Price: $0.0129
Daily Change: +$0.0₃28 / 2.17%
Daily Range: $0.0111 - $0.0131
Market Cap: $5,273,906
Daily Volume: 95,613
Performance Metrics
1 Week: 8.33%
1 Month: -11.56%
3 Months: -39.53%
6 Months: 124.1%
1 Year: 75.68%
YTD: 160.0%
Details
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.